FRIDAY, DECEMBER 5, 2025 1:15:59 PM
My Quest A/c
Online Trading
Employee Email
(A)+
(A)
(A)-
Skip to main content
Equity
|
Currency
|
Mutual Fund
|
IPO
|
Financial Tools
|
e-Voting
Home
|
About Us
|
Product and Services
|
corporate consultancy
|
empowered investor
|
download
|
career
|
contact us
Mission
Vision
Board of Directors
Memberships
Why Quest
Commodity
Currency
Equity and Derivatives
Quest News
Equity
Derivatives
Commodities
MutualFund
IPO
Currency
Depository
SEARCH
Quotes
News
NAV
Daily Market Tracker
Gainers & Losers
Advances & Declines
Value & Volume Toppers
Live Indices
Index Movers
Buyers & Sellers
Bulk Deals
Block Deals
Sector Watch
Market Analysis
New Highs & Lows
52 Week Highs & Lows
Exchange Holidays
Index Constituents
Unusual Volume
Out & Under Performers
Historical Returns
Stock Screener
Company Profile
Detailed Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Share Price
Price Chart
Beta Analysis
Deliverable Volumes
Technical Chart
Corporate Actions
BSE Announcements
Board Meetings
Book Closure
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Change Of Names
Split Of Face Value
Merger & Demerger
Other Markets
ADR Prices
GDR Prices
World Indices
FII Activities
DII Activities
Forex Details
News
Pre-Session
Mid-Session
End-Session
Quick Review
Hot Pursuit
Foreign Markets
Other Markets
Corporate News
Market Beat
Economy News
Currency News
Market Commentary
Mutual Fund News
Commodity News
Corporate Results
Business News
Balance Sheet
Markets > Corporate Information > Balance Sheet
Alivus Life Sciences Ltd
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value
(
R
)
NSE
Symbol
Div Yield
%
Market Cap
(
R
s
.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(
R
)
543322
INE03Q201024
245.7876662
ALIVUS
0.57
10,680.64
20.14
43.23
2
Particulars
Mar 2025
(
R
s
.Cr)
Mar 2024
(
R
s
.Cr)
Mar 2023
(
R
s
.Cr)
Mar 2022
(
R
s
.Cr)
Mar 2021
(
R
s
.Cr)
Mar 2020
(
R
s
.Cr)
SOURCES OF FUNDS :
Share Capital
24.51
24.51
24.51
24.51
1.96
1.96
Reserves Total
2792.87
2307.82
2113.70
2029.81
750.79
399.73
Equity Share Warrants
0.00
0.00
0.00
0.00
0.00
0.00
Equity Application Money
0.00
0.00
0.00
0.00
0.00
0.00
Total Shareholders Funds
2817.38
2332.33
2138.21
2054.32
752.75
401.69
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
56.61
17.15
19.36
2.88
0.00
0.02
Total Debt
56.61
17.15
19.36
2.88
0.00
0.02
Other Liabilities
18.54
15.77
7.87
0.00
0.00
0.00
Total Liabilities
2892.53
2365.25
2165.44
2057.20
752.75
401.71
APPLICATION OF FUNDS :
Gross Block
1218.71
1012.33
936.48
705.53
651.90
594.82
Less : Accumulated Depreciation
263.76
207.26
155.85
115.77
79.10
48.58
Less:Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
954.95
805.07
780.63
589.76
572.80
546.24
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
101.91
105.99
61.62
96.96
14.10
10.73
Producing Properties
0.00
0.00
0.00
0.00
0.00
0.00
Investments
477.69
0.08
0.08
0.08
0.08
0.08
Current Assets, Loans & Advances
Inventories
673.95
666.59
604.17
516.24
513.42
412.78
Sundry Debtors
969.74
765.43
806.77
673.49
619.50
638.63
Cash and Bank Balance
71.24
301.59
309.40
512.16
115.60
10.00
Loans and Advances
142.62
182.38
130.01
62.69
150.52
98.71
Total Current Assets
1857.54
1916.00
1850.34
1764.59
1399.04
1160.12
Less : Current Liabilities and Provisions
Current Liabilities
447.56
424.35
479.53
355.88
1187.85
1285.10
Provisions
16.96
12.03
14.75
26.44
33.60
22.34
Total Current Liabilities & Provisions
464.52
436.38
494.28
382.32
1221.44
1307.44
Net Current Assets
1393.02
1479.62
1356.07
1382.27
177.59
-147.33
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets
7.32
4.55
1.81
1.07
2.03
0.13
Deferred Tax Liability
61.74
53.34
44.25
32.57
24.91
16.58
Net Deferred Tax
-54.42
-48.79
-42.44
-31.50
-22.88
-16.45
Other Assets
19.36
23.29
9.49
19.63
11.06
8.44
Total Assets
2892.51
2365.25
2165.45
2057.20
752.75
401.72
Contingent Liabilities
4.82
4.82
2.22
2.22
2.22
2.22